SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,823.54 -118.08
(-0.23%)

Dow Jones

7,358.68 -19.81
(-0.27%)

Hang Seng

69,065.93 -3,300.41
(-4.56%)

Nikkei 225

10,515.14 -14.75
(-0.14%)

Forex

USD-INR

94.41 -0.14
(-0.15%)

EUR-INR

107.28 -0.07
(-0.07%)

GBP-INR

124.48 -0.08
(-0.06%)

JPY-INR

0.58 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

48.06

19058.03

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.16

Back

afloat enterprises ltd

Arunis Abode reports consolidated net profit of Rs 2.46 crore in the December 2025 quarter

Feb 13,2026

Net profit of Arunis Abode reported to Rs 2.46 crore in the quarter ended December 2025 as against net loss of Rs 0.20 crore during the previous quarter ended December 2024. Sales reported to Rs 15.09 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.09	0	0
OPM %	28.50	0	-
PBDT	4.92	-0.24	LP
PBT	3.66	-0.27	LP
NP	2.46	-0.20	LP

77,100.47 109.25 ( 0.14%)

51,823.54 -118.08 (-0.23%)

7,358.68 -19.81 (-0.27%)

69,065.93 -3,300.41 (-4.56%)

10,515.14 -14.75 (-0.14%)

94.41 -0.14 (-0.15%)

107.28 -0.07 (-0.07%)

124.48 -0.08 (-0.06%)

0.58 0.00 (-0.20%)